Publication | Closed Access

The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study

HepatologyHealth SciencesHepatocellular CarcinomaMedicineSorafenib TreatmentOncologic ImagingLiver CancerAdvanced Hepatocellular CarcinomaOncologyRadiation OncologyNuclear MedicineRadiologyPilot Study